Trending...
- Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
GREENSBORO, N.C., June 1, 2023 ~ Fuse Oncology, an oncology software solutions company, has announced the successful closing of its oversubscribed Series A. Cone Health Ventures and Northeast Georgia Health Ventures (NGHV) were among the largest contributors to the round. The investments will be used to accelerate the expansion of Fuse Oncology's first commercial product, S!GNAL, and develop additional solutions in the radiation oncology market.
James Bauler, CEO of Fuse Oncology, Inc., expressed his gratitude for the investors' enthusiasm and interest in their product. "We are grateful for the interest and enthusiasm of investors who understand the significant impact of our product and our potential to thrive in the market," said Bauler.
Fuse Oncology was spun out of Cone Health and signed its first revenues in quarter one of 2022. Their technology is designed to address key challenges that face radiation oncology departments by automatically identifying and tracking missing documentation, incomplete tasks and orders, as well as wrong charges entered.
More on ncarol.com
John Miller, chief investment officer at Cone Health, expressed his confidence in leading this funding round to support Fuse Oncology's growth. "Fuse has made phenomenal progress in establishing a foothold in the radiation oncology market," said Miller. "We are confident in leading this funding round to support their growth and help expand their reach."
S!GNAL technology from Fuse Oncology catches issues before they materialize to drastically improve revenue cycle and clinical staff workflows. By minimizing mistakes in coding and documentation processes, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in patient engagement cycles to reduce average time to treatment.
Stuart Burri, MD, chairman of radiation oncology at Levine Cancer Institute, president of Southeast Radiation Oncology Group (SERO), and an early investor continues to support Fuse Oncology's advancement. "Fuse's rapid expansion in local radiation oncology centers has changed the way we're thinking about business," said Dr Burri. "It's exciting to reimagine a seamless workflow and data experience between radiation oncology departments and health systems."
Fuse Oncology's Series A closing marks a major milestone for them as they continue their mission to make rad onc departments more efficient while supporting substantial growth in volumes and revenues throughout 2023.
James Bauler, CEO of Fuse Oncology, Inc., expressed his gratitude for the investors' enthusiasm and interest in their product. "We are grateful for the interest and enthusiasm of investors who understand the significant impact of our product and our potential to thrive in the market," said Bauler.
Fuse Oncology was spun out of Cone Health and signed its first revenues in quarter one of 2022. Their technology is designed to address key challenges that face radiation oncology departments by automatically identifying and tracking missing documentation, incomplete tasks and orders, as well as wrong charges entered.
More on ncarol.com
- Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
- Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
- Beneath the Cloudline Explores Hope After Collapse in a New YA Science-Fantasy Novel
- Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
- Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
John Miller, chief investment officer at Cone Health, expressed his confidence in leading this funding round to support Fuse Oncology's growth. "Fuse has made phenomenal progress in establishing a foothold in the radiation oncology market," said Miller. "We are confident in leading this funding round to support their growth and help expand their reach."
S!GNAL technology from Fuse Oncology catches issues before they materialize to drastically improve revenue cycle and clinical staff workflows. By minimizing mistakes in coding and documentation processes, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in patient engagement cycles to reduce average time to treatment.
Stuart Burri, MD, chairman of radiation oncology at Levine Cancer Institute, president of Southeast Radiation Oncology Group (SERO), and an early investor continues to support Fuse Oncology's advancement. "Fuse's rapid expansion in local radiation oncology centers has changed the way we're thinking about business," said Dr Burri. "It's exciting to reimagine a seamless workflow and data experience between radiation oncology departments and health systems."
Fuse Oncology's Series A closing marks a major milestone for them as they continue their mission to make rad onc departments more efficient while supporting substantial growth in volumes and revenues throughout 2023.
Filed Under: Business
0 Comments
Latest on ncarol.com
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
- Gateway Center Arena Announces Duane Curry as General Manger
- New from Regal House Publishing, The Parliament of Mice, classic animal fables retold as satires
- XRPPower Expands Platform Security With Enhanced Brand Protection and Official Verification Standards
- Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- New Book gives Consumer Goods Leaders a Governance Playbook for Generative and Agentic AI
- Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
- Black Ribbon Productions Launches With Fearless 2026 Horror Slate
- Actor Dominic Pace Returns to Television and Film
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
- Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
- RPR Promotes Emily Line to Chief Strategy Officer and Janine Sieja to Chief Product Officer